Literature DB >> 28198586

Influence of a critical single nucleotide polymorphism on nuclear receptor PXR-promoter function.

Manjul Rana1, Poonam Coshic2, Ravinder Goswami3, Rakesh K Tyagi1.   

Abstract

The Pregnane and Xenobiotic Receptor (PXR; NR1I2) is a ligand-modulated transcription factor that belongs to the nuclear receptor superfamily. It is expressed at higher levels primarily in liver and intestine as compared to the levels in several other organs. It is activated by a broad spectrum of xenobiotics and endobiotics. The primary function of PXR is to regulate the expression of drug metabolizing enzymes and transporters and prevent the accumulation of toxic chemicals in the body, thereby maintaining body's homeostasis. In this study, we identified a C/T single nucleotide polymorphism at position -831 from the transcriptional start site of the PXR gene promoter and examined the functional significance of this variant using both the luciferase reporter gene assays and electrophoretic mobility shift assays (EMSA). Transient transfection experiments showed that the T-allele was associated with significantly greater transcriptional activity than the C-allele of SNP rs3814055. These results indicate that the -831C/T polymorphism has a direct effect on transcriptional regulation of PXR gene. This allelic variation may be a potential genetic marker that can help identify individuals at higher risk for Inflammatory Bowel Disease (IBD).
© 2017 International Federation for Cell Biology.

Entities:  

Keywords:  IBD; PXR; gene expression; promoter; single nucleotide polymorphism

Mesh:

Substances:

Year:  2017        PMID: 28198586     DOI: 10.1002/cbin.10744

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  6 in total

Review 1.  Why We Need to Take a Closer Look at Genetic Contributions to CYP3A Activity.

Authors:  Qinglian Zhai; Maaike van der Lee; Teun van Gelder; Jesse J Swen
Journal:  Front Pharmacol       Date:  2022-06-16       Impact factor: 5.988

2.  Characterization of human pregnane X receptor activators identified from a screening of the Tox21 compound library.

Authors:  Caitlin Lynch; Srilatha Sakamuru; Ruili Huang; Jake Niebler; Stephen S Ferguson; Menghang Xia
Journal:  Biochem Pharmacol       Date:  2020-12-14       Impact factor: 6.100

3.  NR1I2 genetic polymorphisms and the risk of anti-tuberculosis drug-induced hepatotoxicity: A systematic review and meta-analysis.

Authors:  Miaomiao Yang; Yunliang Qiu; Yanyu Jin; Wenpei Liu; Qingliang Wang; Honggang Yi; Shaowen Tang
Journal:  Pharmacol Res Perspect       Date:  2020-12

4.  A preliminary computational outputs versus experimental results: Application of sTRAP, a biophysical tool for the analysis of SNPs of transcription factor-binding sites.

Authors:  Shirin Moradifard; Reza Saghiri; Parastoo Ehsani; Fatemeh Mirkhani; Mina Ebrahimi-Rad
Journal:  Mol Genet Genomic Med       Date:  2020-03-10       Impact factor: 2.183

5.  Genetic polymorphisms in PXR and NF-κB1 influence susceptibility to anti-tuberculosis drug-induced liver injury.

Authors:  Jingwei Zhang; Zhenzhen Zhao; Hao Bai; Minjin Wang; Lin Jiao; Wu Peng; Tao Wu; Tangyuheng Liu; Hao Chen; Xingbo Song; Lijuan Wu; Xuejiao Hu; Qian Wu; Juan Zhou; Jiajia Song; Mengyuan Lyv; Binwu Ying
Journal:  PLoS One       Date:  2019-09-06       Impact factor: 3.240

6.  Activation of PXR by alantolactone ameliorates DSS-induced experimental colitis via suppressing NF-κB signaling pathway.

Authors:  Yijing Ren; Bei Yue; Gaiyan Ren; Zhilun Yu; Xiaoping Luo; Aning Sun; Jingjing Zhang; Mengqing Han; Zhengtao Wang; Wei Dou
Journal:  Sci Rep       Date:  2019-11-12       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.